{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/candida-skin/background-information/causes-risk-factors/","result":{"pageContext":{"chapter":{"id":"82ae2b5c-db02-50a0-9572-a12b245c9f9f","slug":"causes-risk-factors","fullItemName":"Causes and risk factors","depth":2,"htmlHeader":"<!-- begin field 2fd611d0-4f40-4bfb-8c64-d7f43b5e995d --><h2>What are the causes and risk factors for candidal skin infections?</h2><!-- end field 2fd611d0-4f40-4bfb-8c64-d7f43b5e995d -->","summary":"","htmlStringContent":"<!-- begin item 5db12c9c-da10-4f5e-9a61-224a086d1477 --><!-- begin field a6ae7996-525c-453e-8907-e3a19cfe5797 --><ul><li><strong>There are over 20 <em>Candida</em> species that can cause infection in humans </strong>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/candida-skin/references/\">CDC, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/candida-skin/references/\">Primary Care Dermatology Society, 2016a</a>]<strong>.</strong><ul><li><em>Candida albicans</em> is the most common species and is responsible for over half of candidal skin infections. Other species, such as <em>C. tropicalis</em>, <em>C. glabrata, C. parapsilosis, and C. krusei,</em> are far less common but may overgrow and cause candidiasis in high-risk people [<a class=\"bibliography-reference internal-reference\" href=\"/topics/candida-skin/references/\">Evans and Gray, 2003</a>]. </li><li>Each of these organisms has unique virulence potential, antifungal susceptibility, and epidemiology.</li></ul></li><li><strong>Candidal skin infection is more likely where skin rubs on skin (such as between skin folds in an obese person) and where heat and moisture lead to maceration and inflammation </strong>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/candida-skin/references/\">Mistiaen et al, 2004</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/candida-skin/references/\">Kalra, 2014</a>]<strong>.</strong> Other risk factors include [<a class=\"bibliography-reference internal-reference\" href=\"/topics/candida-skin/references/\">DermNet NZ, 2003</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/candida-skin/references/\">Primary Care Dermatology Society, 2016b</a>]:<ul><li>Immunocompromise (such as due to HIV infection, chemotherapy, and the use of immunosuppressive drugs [such as corticosteroids]).</li><li>General debility, for example from cancer or malnutrition. </li><li>Recent or concurrent use of drugs that promote candidal growth, particularly broad-spectrum antibiotics and inhaled or oral corticosteroids.</li><li>Extremes of ages — due to immature or weakened immunity. </li><li>Diseases in which the barrier function of the skin is disturbed (such as psoriasis and seborrhoeic eczema).</li><li>Endocrine disorders, such as:<ul><li>Diabetes mellitus — see the CKS topics on <a class=\"topic-reference external-reference\" href=\"/topics/diabetes-type-1/\">Diabetes - type 1</a> and <a class=\"topic-reference external-reference\" href=\"/topics/diabetes-type-2/\">Diabetes - type 2</a> for more information. </li><li>Cushing's syndrome. </li></ul></li><li>Iron deficiency anaemia — iron is the most common deficient essential micronutrient implicated in the colonization of <em>Candida</em>, as iron deficiency diminishes the fungistatic action of transferrin and other iron-dependant enzymes. See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/anaemia-iron-deficiency/\">Anaemia - iron deficiency</a> for more information.</li><li>High-oestrogen contraceptive pill or pregnancy.</li><li>Poor hygiene.</li></ul></li></ul><!-- end field a6ae7996-525c-453e-8907-e3a19cfe5797 --><!-- end item 5db12c9c-da10-4f5e-9a61-224a086d1477 -->","topic":{"id":"0d4d1ca9-1f95-59a6-9163-91faf2fce35e","topicId":"44d93cc7-56e9-4f35-92ee-6fe5c97d5646","topicName":"Candida - skin","slug":"candida-skin","lastRevised":"Last revised in May 2017","chapters":[{"id":"fdd77154-68fd-5e12-ab34-4980d82ec2e8","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"20e27b79-2755-56d0-811f-79d59b1ad973","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"dc171785-2e5e-50c2-9f57-0cd56c75a2d7","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"9ce37f9c-5801-5953-acaa-da119b97818f","slug":"changes","fullItemName":"Changes"},{"id":"a9f51671-bb82-536e-9b5f-c98cb41291e6","slug":"update","fullItemName":"Update"}]},{"id":"6f439137-5e54-571e-b7aa-8cce9c5c58f6","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"7433f221-a6d1-5f98-a53d-32009abd6d65","slug":"goals","fullItemName":"Goals"},{"id":"c1df0f9d-1fa3-5aa3-96a3-7636250c141a","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"1edcd62f-0185-5317-a25a-afb5e18d3d5e","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"e514a54c-ae49-5bb6-9c8e-0de16f244409","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"00336847-83a8-540e-954e-23801c8eb472","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"99dacab6-3fed-5a48-ad05-74876122fa41","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"7884dd9b-ba26-56fe-8b96-29022de73f28","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"3aa00866-7e3b-5a84-9b01-091a915acd1e","slug":"definition","fullItemName":"Definition"},{"id":"82ae2b5c-db02-50a0-9572-a12b245c9f9f","slug":"causes-risk-factors","fullItemName":"Causes and risk factors"},{"id":"16b02723-03c7-5877-8f98-955d9ba0adda","slug":"complications-prognosis","fullItemName":"Complications and prognosis"}]},{"id":"3e942288-d611-5acc-a0a5-79c5a9bbf5c3","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"815a9379-3ee5-585a-997e-8daf2e138d95","slug":"diagnosis","fullItemName":"Diagnosis"},{"id":"556293f9-6cf5-5f40-bdd2-06dfff1c5b82","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"d48752d8-0979-5908-b55c-40d0bf50e947","fullItemName":"Management","slug":"management","subChapters":[{"id":"187d27a6-4a3a-59f4-99c1-33a221ca0d2b","slug":"management","fullItemName":"Scenario: Management"}]},{"id":"ab1b23e6-6d8b-5003-bdea-20df2a09e2b1","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"216d1aaa-ae60-548d-b753-0c53f672a4ad","slug":"topical-antifungals","fullItemName":"Topical antifungals"},{"id":"a6376d8b-e282-52b4-a990-ceb7d73afaf3","slug":"oral-fluconazole","fullItemName":"Oral fluconazole"}]},{"id":"1b822a63-5645-5cdc-9a82-7e61da577351","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"6bcfeaf8-f78c-5867-99f3-adb4fde508db","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"e9a0750e-9090-547a-aac2-eea9118c16c8","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"7624a8b0-8f03-5842-b47f-0374a546f628","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"e3980da9-5b2b-5ebb-a7ed-7edcff958155","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"e3941da5-da7c-5313-b272-7df5b0bd2985","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"0839e574-758e-59d0-8520-6335161c5e49","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"3603b783-48c3-58d3-a191-1fb1ff30eca8","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"7884dd9b-ba26-56fe-8b96-29022de73f28","slug":"background-information","fullItemName":"Background information"},"subChapters":[]}}},"staticQueryHashes":["3666801979"]}